Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Amdocs (DOX) EBITDA (2016 - 2025)

Amdocs (DOX) has disclosed EBITDA for 13 consecutive years, with $132.6 million as the latest value for Q3 2025.

  • On a quarterly basis, EBITDA rose 17.71% to $132.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $555.9 million, a 3.19% decrease, with the full-year FY2025 number at $731.7 million, up 16.39% from a year prior.
  • EBITDA was $132.6 million for Q3 2025 at Amdocs, up from $112.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $171.7 million in Q3 2022 to a low of $112.7 million in Q3 2024.
  • A 5-year average of $141.4 million and a median of $138.9 million in 2023 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: dropped 19.08% in 2023, then increased 17.71% in 2025.
  • Amdocs' EBITDA stood at $151.0 million in 2021, then increased by 13.73% to $171.7 million in 2022, then decreased by 19.08% to $138.9 million in 2023, then dropped by 18.9% to $112.7 million in 2024, then grew by 17.71% to $132.6 million in 2025.
  • Per Business Quant, the three most recent readings for DOX's EBITDA are $132.6 million (Q3 2025), $112.7 million (Q3 2024), and $138.9 million (Q3 2023).